3710 results for «2021»

Filter By

3710 results

Management of heavy calcified bifurcation lesions

21 May 2025 – From EuroPCR 2025

This session focuses on the management of heavily calcified bifurcation lesions using advanced techniques such as IVUS guided guidewire recrossing and orbital atherectomy. Learn step-by-step approaches to tackle complex calcific coronary bifurcations and improve procedural success.

Management of heavy calcified bifurcation lesions

My worst PCI complication: how did I treat and could I have prevented it?

21 May 2025 – From EuroPCR 2025

Learn practical strategies to manage life-threatening PCI complications through real case studies. This session highlights techniques and devices employed to overcome complications, preventive measures, and safe outcome optimization during complex interventions.

My worst PCI complication: how did I treat and could I have prevented it?

Tips for challenging TAVI scenarios

21 May 2025 – From EuroPCR 2025

Explore expert tips for navigating challenging TAVI scenarios including cases with stent entrapment, extremely large annuli, and rare anatomical conditions like Klippel Feil syndrome. Understand approaches for intraannular valve prosthesis implantation in complex coronary anatomy.

Tips for challenging TAVI scenarios

How to deal with left main culprit in NSTEMI

21 May 2025 – From EuroPCR 2025

This session offers a cross-geographic exchange on managing left main culprit lesions in NSTEMI patients. Learn different interventional approaches, risk evaluation for periprocedural complications, and diverse PCI management strategies tailored to this complex subgroup.

How to deal with left main culprit in NSTEMI

Chronic coronary syndrome with low ejection fraction and left ventricle support

21 May 2025 – From EuroPCR 2025

This session examines the management of chronic coronary syndrome in patients with low ejection fraction, emphasizing the role of left ventricular support. Topics include risks of intracoronary imaging, pharmacological facilitation, mechanical circulatory support, and alternatives like LAVA-ECMO.

Chronic coronary syndrome with low ejection fraction and left ventricle support

Through decisions in complex left main PCI - Isolated ostial left circumflex

21 May 2025 – From EuroPCR 2025

Navigate complex isolated ostial left circumflex lesions with a focus on the integration of imaging and physiological assessment. Learn treatment options and optimisation strategies to improve long-term outcomes in left main PCI through detailed case presentations and expert guidance.

Through decisions in complex left main PCI - Isolated ostial left circumflex

Coronary dissection : when imaging makes the difference

21 May 2025 – From EuroPCR 2025

Explore the critical role of intracoronary imaging in diagnosing and managing coronary dissections and related complications. Through case studies, learn about bailout strategies and the domino effect of decisions during PCI in acute myocardial infarction.

Coronary dissection : when imaging makes the difference

DCB in challenging scenarios - Part 2

20 May 2025 – From EuroPCR 2025

Explore the application of drug-coated balloons (DCB) in challenging coronary scenarios with a focus on recurrent calcified stenosis, in-stent restenosis, and left main interventions. This session includes case discussions on plaque phenotype-guided DCB treatment, 'leave nothing behind' strategy, and complex left main PCI using kissing DCBs...

DCB in challenging scenarios - Part 2

Amulet IDE: Amplatzer Amulet Left Atrial Appendage Occluder RCT - 12-Month Closure Follow-up

04 Nov 2021

Ali Nazmi Calik reviews Amulet IDE, a prospective, randomized, multi-center and active-control trial designed to compare the Amulet and Watchman 2.5 devices in a head-to-head fashion, and presented by Dhanunjaya Lakkireddy during TCT 2021.

Author

Ali Nazmi Calik
AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion

PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

07 Nov 2021

Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.

Giuseppe Biondi Zoccai

Author

Giuseppe Biondi-Zoccai
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

06 Nov 2021

TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.

Author

Radoslaw Parma
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

04 Nov 2021

TCT 2021: Luis Ortega Paz interviews Rafael Romaguera, principal investigator of the SUGAR trial. SUGAR is the first powered trial to compare new generation DES in patients with diabetes, and also the first to include a broad population of patients with diabetes (all-comers design). It was...

Luis Ortega-Paz

Author

Luis Ortega-Paz
Rafael Romaguera

Author

Rafael Romaguera
SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

18 May 2021

Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis

01 Jun 2021

The value of elective coronary revascularisation plus medical therapy over medical therapy alone in managing stable patients with coronary artery disease is debated. Hence, the authors reviewed all trials comparing the two strategies in this population to appraise whether revascularisation in addition to medical therapy affects...

Elad Asher

Reviewer

Elad Asher
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis

Learn the latest from the PCR Tricuspid Focus Group!

Launch the video to hear Marianna Adamo and Marta Sitges share how they and Julien Dreyfus strengthened the Leadership team at the end of last year, bringing welcome support to founders Francesco Maisano and Fabien Praz.
 
They explain their individual roles among the PCR Tricuspid Focus Group;...

Learn the latest from the PCR Tricuspid Focus Group!

World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!

29 Sep 2023

Global burden of Cardiovascular Disease

Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...

Vijay Kunadian

Author

Vijay Kunadian
World Heart Day 2023

Season’s greetings from the Chairman and Vice-Chairman of PCR

22 Dec 2020

 
Dear Colleagues, dear Friends, dear Companions,
 
Putting ‘pen to paper’ to draft the season’s greetings and looking back on 2020, we must share with you that this year our good wishes are rather more solemn than usual.

Indeed, as we entered the decade back in January, we...

PCR Wishes you a happy new year!

LIVE EAPCI-PCR Fellows Course - Coronary Track - #1 & #2

14 Apr 2021

Free livestreamed episodes #1 and #2, with live chat for Fellows (coronary track), taking place on 14 April 2021

LIVE EAPCI-PCR Fellows Course - Valvular Track - #1

14 Apr 2021

Free livestreamed episode #1 with live chat for Fellows (valvular track), taking place on 14 April 2021

LIVE EAPCI-PCR Fellows Course - Coronary Track - #3 & #4

28 Apr 2021

Free livestreamed episodes with live chat for Fellows (coronary track), taking place on 28 April 2021

Didn’t find what you were looking for?